<?xml version="1.0" encoding="UTF-8"?><!--Generated by ParsePort ApS--><?instance-generator id="ParsePort XBRL Generator" version="2018.05.24" creationdate="2022-06-27T10:11:48+01:00"?><xbrli:xbrl xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:gsd="http://xbrl.dcca.dk/gsd" xmlns:cmn="http://xbrl.dcca.dk/cmn" xmlns:sob="http://xbrl.dcca.dk/sob" xmlns:fsa="http://xbrl.dcca.dk/fsa" xmlns:arr="http://xbrl.dcca.dk/arr" xmlns:mrv="http://xbrl.dcca.dk/mrv" xmlns:iso4217="http://www.xbrl.org/2003/iso4217"><link:schemaRef xlink:href="http://archprod.service.eogs.dk/taxonomy/20171001/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20171001.xsd" xlink:type="simple" /><xbrli:unit id="pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="DKK"><xbrli:measure>iso4217:DKK</xbrli:measure></xbrli:unit><xbrli:context id="duration_CY_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="duration_CY_IdentificationOfMemberOfSupervisoryBoardDimension_cmn_memberOfBoardIdentifier_only_1"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfSupervisoryBoardDimension"><cmn:memberOfBoardIdentifier>1</cmn:memberOfBoardIdentifier></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="duration_CY_IdentificationOfMemberOfSupervisoryBoardDimension_cmn_memberOfBoardIdentifier_only_2"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfSupervisoryBoardDimension"><cmn:memberOfBoardIdentifier>2</cmn:memberOfBoardIdentifier></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="duration_CY_IdentificationOfMemberOfSupervisoryBoardDimension_cmn_memberOfBoardIdentifier_only_3"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfSupervisoryBoardDimension"><cmn:memberOfBoardIdentifier>3</cmn:memberOfBoardIdentifier></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="duration_CY_IdentificationOfMemberOfExecutiveBoardDimension_cmn_memberOfBoardIdentifier_only_1"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfExecutiveBoardDimension"><cmn:memberOfBoardIdentifier>1</cmn:memberOfBoardIdentifier></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="duration_CY_IdentificationOfAuditorDimension_cmn_auditorIdentifier_only_1"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="cmn:IdentificationOfAuditorDimension"><cmn:auditorIdentifier>1</cmn:auditorIdentifier></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="duration_LY_RetrospectiveInformationDimension_cmn_PreviousYearMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="cmn:RetrospectiveInformationDimension">cmn:PreviousYearMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="duration_2Y_RetrospectiveInformationDimension_cmn_TwoYearsAgoMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="cmn:RetrospectiveInformationDimension">cmn:TwoYearsAgoMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="duration_3Y_RetrospectiveInformationDimension_cmn_ThreeYearsAgoMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="cmn:RetrospectiveInformationDimension">cmn:ThreeYearsAgoMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="duration_4Y_RetrospectiveInformationDimension_cmn_FourYearsAgoMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="cmn:RetrospectiveInformationDimension">cmn:FourYearsAgoMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="duration_LY_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="duration_CY_ResultDistributionDimension_fsa_ProposedDividendRecognisedInEquityMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ResultDistributionDimension">fsa:ProposedDividendRecognisedInEquityMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="duration_LY_ResultDistributionDimension_fsa_ProposedDividendRecognisedInEquityMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ResultDistributionDimension">fsa:ProposedDividendRecognisedInEquityMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="duration_CY_ResultDistributionDimension_fsa_RetainedEarningsMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ResultDistributionDimension">fsa:RetainedEarningsMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="duration_LY_ResultDistributionDimension_fsa_RetainedEarningsMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ResultDistributionDimension">fsa:RetainedEarningsMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="duration_CY_ClassesOfEquityDimension_fsa_ContributedCapitalMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ClassesOfEquityDimension">fsa:ContributedCapitalMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="duration_CY_ClassesOfEquityDimension_fsa_RetainedEarningsMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ClassesOfEquityDimension">fsa:RetainedEarningsMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="duration_CY_ClassesOfEquityDimension_fsa_ProposedDividendRecognisedInEquityMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ClassesOfEquityDimension">fsa:ProposedDividendRecognisedInEquityMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="instant_CY_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="instant_LY_RetrospectiveInformationDimension_cmn_PreviousYearMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="cmn:RetrospectiveInformationDimension">cmn:PreviousYearMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="instant_2Y_RetrospectiveInformationDimension_cmn_TwoYearsAgoMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="cmn:RetrospectiveInformationDimension">cmn:TwoYearsAgoMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="instant_3Y_RetrospectiveInformationDimension_cmn_ThreeYearsAgoMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="cmn:RetrospectiveInformationDimension">cmn:ThreeYearsAgoMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="instant_4Y_RetrospectiveInformationDimension_cmn_FourYearsAgoMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="cmn:RetrospectiveInformationDimension">cmn:FourYearsAgoMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="instant_LY_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="instant_CY_ClassesOfEquityDimension_fsa_ContributedCapitalMember_only_start"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ClassesOfEquityDimension">fsa:ContributedCapitalMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="instant_CY_ClassesOfEquityDimension_fsa_ContributedCapitalMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ClassesOfEquityDimension">fsa:ContributedCapitalMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="instant_CY_ClassesOfEquityDimension_fsa_RetainedEarningsMember_only_start"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ClassesOfEquityDimension">fsa:RetainedEarningsMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="instant_CY_ClassesOfEquityDimension_fsa_RetainedEarningsMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ClassesOfEquityDimension">fsa:RetainedEarningsMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="instant_CY_ClassesOfEquityDimension_fsa_ProposedDividendRecognisedInEquityMember_only_start"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ClassesOfEquityDimension">fsa:ProposedDividendRecognisedInEquityMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="instant_CY_ClassesOfEquityDimension_fsa_ProposedDividendRecognisedInEquityMember_only"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ClassesOfEquityDimension">fsa:ProposedDividendRecognisedInEquityMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="instant_CY_only_start"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">26688949</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><gsd:InformationOnTypeOfSubmittedReport contextRef="duration_CY_only">Annual report</gsd:InformationOnTypeOfSubmittedReport><cmn:TypeOfAuditorAssistance contextRef="duration_CY_only">Auditor's report on audited financial statements</cmn:TypeOfAuditorAssistance><sob:TheReportingEntityAppliesTheExceptionConcerningOptingOutOfTheStatementByManagementEtc contextRef="duration_CY_only">false</sob:TheReportingEntityAppliesTheExceptionConcerningOptingOutOfTheStatementByManagementEtc><fsa:ClassOfReportingEntity contextRef="duration_CY_only">Reporting class B</fsa:ClassOfReportingEntity><fsa:SelectedElementsFromReportingClassC contextRef="duration_CY_only">true</fsa:SelectedElementsFromReportingClassC><fsa:SelectedElementsFromReportingClassD contextRef="duration_CY_only">false</fsa:SelectedElementsFromReportingClassD><fsa:AccountingPoliciesAreUnchangedFromPreviousPeriod contextRef="duration_CY_only">false</fsa:AccountingPoliciesAreUnchangedFromPreviousPeriod><gsd:NameOfReportingEntity contextRef="duration_CY_only">UCB NORDIC A/S</gsd:NameOfReportingEntity><gsd:AddressOfReportingEntityStreetName contextRef="duration_CY_only">Edvard Thomsens Vej</gsd:AddressOfReportingEntityStreetName><gsd:AddressOfReportingEntityStreetBuildingIdentifier contextRef="duration_CY_only">14, 7.</gsd:AddressOfReportingEntityStreetBuildingIdentifier><gsd:AddressOfReportingEntityPostCodeIdentifier contextRef="duration_CY_only">2300</gsd:AddressOfReportingEntityPostCodeIdentifier><gsd:AddressOfReportingEntityDistrictName contextRef="duration_CY_only">København S</gsd:AddressOfReportingEntityDistrictName><gsd:TelephoneNumberOfReportingEntity contextRef="duration_CY_only">+4532462400</gsd:TelephoneNumberOfReportingEntity><gsd:FaxNumberOfReportingEntity contextRef="duration_CY_only">+4532462401</gsd:FaxNumberOfReportingEntity><gsd:HomepageOfReportingEntity contextRef="duration_CY_only">www.ucb.com</gsd:HomepageOfReportingEntity><gsd:IdentificationNumberCvrOfReportingEntity contextRef="duration_CY_only">26688949</gsd:IdentificationNumberCvrOfReportingEntity><gsd:DateOfFoundationOfReportingEntity contextRef="duration_CY_only">2002-07-05</gsd:DateOfFoundationOfReportingEntity><gsd:RegisteredOfficeOfReportingEntity contextRef="duration_CY_only">Copenhagen</gsd:RegisteredOfficeOfReportingEntity><gsd:ReportingPeriodStartDate contextRef="duration_CY_only">2021-01-01</gsd:ReportingPeriodStartDate><gsd:ReportingPeriodEndDate contextRef="duration_CY_only">2021-12-31</gsd:ReportingPeriodEndDate><gsd:PrecedingReportingPeriodStartDate contextRef="duration_CY_only">2020-01-01</gsd:PrecedingReportingPeriodStartDate><gsd:PredingReportingPeriodEndDate contextRef="duration_CY_only">2020-12-31</gsd:PredingReportingPeriodEndDate><gsd:DateOfGeneralMeeting contextRef="duration_CY_only">2022-06-23</gsd:DateOfGeneralMeeting><gsd:NameAndSurnameOfChairmanOfGeneralMeeting contextRef="duration_CY_only">Ana Isabel Infante Gonzalez</gsd:NameAndSurnameOfChairmanOfGeneralMeeting><cmn:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="duration_CY_IdentificationOfMemberOfSupervisoryBoardDimension_cmn_memberOfBoardIdentifier_only_1">Ana Isabel Infante Gonzalez De La Aleja</cmn:NameAndSurnameOfMemberOfSupervisoryBoard><cmn:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="duration_CY_IdentificationOfMemberOfSupervisoryBoardDimension_cmn_memberOfBoardIdentifier_only_2">Per Ove Jonas Berg</cmn:NameAndSurnameOfMemberOfSupervisoryBoard><cmn:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="duration_CY_IdentificationOfMemberOfSupervisoryBoardDimension_cmn_memberOfBoardIdentifier_only_3">Afshin Risseh</cmn:NameAndSurnameOfMemberOfSupervisoryBoard><cmn:NameAndSurnameOfMemberOfExecutiveBoard contextRef="duration_CY_IdentificationOfMemberOfExecutiveBoardDimension_cmn_memberOfBoardIdentifier_only_1">Mari-Ann Retz</cmn:NameAndSurnameOfMemberOfExecutiveBoard><cmn:NameOfAuditFirm contextRef="duration_CY_IdentificationOfAuditorDimension_cmn_auditorIdentifier_only_1">Mazars Statsautoriseret Revisionspartnerselskab</cmn:NameOfAuditFirm><gsd:AddressOfAuditorStreetName contextRef="duration_CY_IdentificationOfAuditorDimension_cmn_auditorIdentifier_only_1">Midtermolen</gsd:AddressOfAuditorStreetName><gsd:AddressOfAuditorStreetBuildingIdentifier contextRef="duration_CY_IdentificationOfAuditorDimension_cmn_auditorIdentifier_only_1">1, 2. tv.</gsd:AddressOfAuditorStreetBuildingIdentifier><gsd:AddressOfAuditorPostCodeIdentifier contextRef="duration_CY_IdentificationOfAuditorDimension_cmn_auditorIdentifier_only_1">2100</gsd:AddressOfAuditorPostCodeIdentifier><gsd:AddressOfAuditorDistrictName contextRef="duration_CY_IdentificationOfAuditorDimension_cmn_auditorIdentifier_only_1">København Ø</gsd:AddressOfAuditorDistrictName><cmn:IdentificationNumberCvrOfAuditFirm contextRef="duration_CY_IdentificationOfAuditorDimension_cmn_auditorIdentifier_only_1">31061741</cmn:IdentificationNumberCvrOfAuditFirm><gsd:NameOfSubmittingEnterprise contextRef="duration_CY_only">Mazars Statsautoriseret Revisionspartnerselskab</gsd:NameOfSubmittingEnterprise><gsd:AddressOfSubmittingEnterpriseStreetAndNumber contextRef="duration_CY_only">Midtermolen 1, 2. tv.</gsd:AddressOfSubmittingEnterpriseStreetAndNumber><gsd:AddressOfSubmittingEnterprisePostcodeAndTown contextRef="duration_CY_only">2100 København Ø</gsd:AddressOfSubmittingEnterprisePostcodeAndTown><gsd:IdentificationNumberCvrOfSubmittingEnterprise contextRef="duration_CY_only">31061741</gsd:IdentificationNumberCvrOfSubmittingEnterprise><sob:StatementByExecutiveAndSupervisoryBoards contextRef="duration_CY_only">The Board of Directors and Executive Board have today discussed and approved the Annual Report of&lt;br/&gt;UCB NORDIC A/S for the financial year 1 January - 31 December 2021.&lt;br/&gt;The annual report is prepared in accordance with the Danish Financial Statements Act.&lt;br/&gt;In our opinion the financial statements give a true and fair view of the Company's assets, liabilities and&lt;br/&gt;financial position at 31 December 2021 and of the results of the company's operations for the financial&lt;br/&gt;year 1 January - 31 December 2021.&lt;br/&gt;Further, in our opinion, the Management's review gives a fair review of the development in the Company’s&lt;br/&gt;operations and financial matters, of the results for the year and of the Company’s financial position.&lt;br/&gt;We recommend that the Annual Report be approved at the Annual General Meeting.</sob:StatementByExecutiveAndSupervisoryBoards><sob:PlaceOfSignatureOfStatement contextRef="duration_CY_only">Copenhagen</sob:PlaceOfSignatureOfStatement><sob:DateOfApprovalOfAnnualReport contextRef="duration_CY_only">2022-06-23</sob:DateOfApprovalOfAnnualReport><arr:AddresseeOfAuditorsReportOnAuditedFinancialStatements contextRef="duration_CY_only">To the shareholder of UCB NORDIC A/S</arr:AddresseeOfAuditorsReportOnAuditedFinancialStatements><arr:TypeOfModifiedOpinionOnAuditedFinancialStatements contextRef="duration_CY_only">Opinion</arr:TypeOfModifiedOpinionOnAuditedFinancialStatements><arr:OpinionOnAuditedFinancialStatements contextRef="duration_CY_only">In our opinion, the Financial Statements give a true and fair view of the Company’s assets, liabilities and&lt;br/&gt;financial position of the Company at 31 December 2021, and of the results of the Company’s operations&lt;br/&gt;for the financial year 1 January - 31 December 2021 in accordance with the Danish Financial Statements&lt;br/&gt;Act.&lt;br/&gt;We have audited the Financial Statements of UCB NORDIC A/S for the financial year 1 January -&lt;br/&gt;31 December 2021, which comprise income statement, balance sheet, statement of changes in equity&lt;br/&gt;and notes, including a summary of significant accounting policies.</arr:OpinionOnAuditedFinancialStatements><arr:TypeOfBasisForModifiedOpinionOnAuditedFinancialStatements contextRef="duration_CY_only">Basis for Opinion</arr:TypeOfBasisForModifiedOpinionOnAuditedFinancialStatements><arr:DescriptionOfQualificationsOfAuditedFinancialStatements contextRef="duration_CY_only">We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional&lt;br/&gt;requirements applicable in Denmark. Our responsibilities under those standards and requirements are&lt;br/&gt;further described in the Auditor’s Responsibilities for the Audit of the Financial Statements section of our&lt;br/&gt;report. We are independent of the Company in accordance with the International Ethics Standards Board&lt;br/&gt;for Accountants’ Code of Ethics for Professional Accountants (IESBA Code) and the additional&lt;br/&gt;requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance&lt;br/&gt;with these requirements. We believe that the audit evidence we have obtained is sufficient and&lt;br/&gt;appropriate to provide a basis for our opinion.</arr:DescriptionOfQualificationsOfAuditedFinancialStatements><arr:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements contextRef="duration_CY_only">Management is responsible for the preparation of Financial Statements that give a true and fair view in&lt;br/&gt;accordance with the Danish Financial Statements Act, and for such internal control as Management&lt;br/&gt;determines is necessary to enable the preparation of financial statements that are free from material&lt;br/&gt;misstatement, whether due to fraud or error.&lt;br/&gt;In preparing the financial statements, Management is responsible for assessing the Company’s ability to&lt;br/&gt;continue as a going concern, disclosing, as applicable, matters related to going concern and using the&lt;br/&gt;going concern basis of accounting in preparing the financial statements unless Management either&lt;br/&gt;intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.</arr:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements><arr:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed contextRef="duration_CY_only">Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are&lt;br/&gt;free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that&lt;br/&gt;includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an&lt;br/&gt;audit conducted in accordance with ISAs and the additional requirements applicable in Denmark will&lt;br/&gt;always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are&lt;br/&gt;considered material if, individually or in the aggregate, they could reasonably be expected to influence the&lt;br/&gt;economic decisions of users taken on the basis of these financial statements.&lt;br/&gt;As part of an audit conducted in accordance with ISAs and the additional requirements applicable in&lt;br/&gt;Denmark, we exercise professional judgment and maintain professional skepticism throughout the audit.&lt;br/&gt;We also:&lt;br/&gt;– Identify and assess the risks of material misstatement of the financial statements, whether due to fraud&lt;br/&gt;or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that&lt;br/&gt;is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material&lt;br/&gt;misstatement resulting from fraud is higher than for one resulting from error as fraud may involve&lt;br/&gt;collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.&lt;br/&gt;– Obtain an understanding of internal control relevant to the audit in order to design audit procedures&lt;br/&gt;that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the&lt;br/&gt;effectiveness of the Company’s internal control.&lt;br/&gt;– Evaluate the appropriateness of accounting policies used and the reasonableness of accounting&lt;br/&gt;estimates and related disclosures made by Management.&lt;br/&gt;– Conclude on the appropriateness of Management’s use of the going concern basis of accounting in&lt;br/&gt;pre-paring the financial statements and, based on the audit evidence obtained, whether a material&lt;br/&gt;uncertainty exists related to events or conditions that may cast significant doubt on the Company’s&lt;br/&gt;ability to continue as a going concern. If we conclude that a material uncertainty exists, we are&lt;br/&gt;required to draw attention in our auditor’s report to the related disclosures in the financial statements&lt;br/&gt;or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit&lt;br/&gt;evidence obtained up to the date of our auditor’s report. However, future events or conditions may&lt;br/&gt;cause the Company to cease to continue as a going concern.&lt;br/&gt;– Evaluate the overall presentation, structure and contents of the financial statements, including the&lt;br/&gt;disclosures, and whether the financial statements represent the underlying transactions and events in&lt;br/&gt;a manner that gives a true and fair view.&lt;br/&gt;We communicate with those charged with governance regarding, among other matters, the planned&lt;br/&gt;scope and timing of the audit and significant audit findings, including any significant deficiencies in&lt;br/&gt;internal control that we identify during our audit.</arr:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed><arr:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements contextRef="duration_CY_only">Management is responsible for Management’s Review.&lt;br/&gt;Our opinion on the financial statements does not cover Management’s Review, and we do not express&lt;br/&gt;any form of assurance conclusion thereon.&lt;br/&gt;In connection with our audit of the financial statements, our responsibility is to read Management’s&lt;br/&gt;Review and, in doing so, consider whether Management’s Review is materially inconsistent with the&lt;br/&gt;financial statements or our knowledge obtained during the audit, or otherwise appears to be materially&lt;br/&gt;misstated.&lt;br/&gt;Moreover, it is our responsibility to consider whether Management’s Review provides the information&lt;br/&gt;required under the Danish Financial Statements Act.&lt;br/&gt;Based on the work we have performed, in our view, Management’s Review is in accordance with the&lt;br/&gt;Financial Statements and has been prepared in accordance with the requirements of the Danish Financial&lt;br/&gt;Statements Act. We did not identify any material misstatement in Management’s Review.</arr:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements><arr:SignatureOfAuditorsPlace contextRef="duration_CY_only">København Ø</arr:SignatureOfAuditorsPlace><arr:SignatureOfAuditorsDate contextRef="duration_CY_only">2022-06-23</arr:SignatureOfAuditorsDate><cmn:NameAndSurnameOfAuditor contextRef="duration_CY_IdentificationOfAuditorDimension_cmn_auditorIdentifier_only_1">Karsten Vedel</cmn:NameAndSurnameOfAuditor><cmn:DescriptionOfAuditor contextRef="duration_CY_IdentificationOfAuditorDimension_cmn_auditorIdentifier_only_1">State Authorised Public Accountant</cmn:DescriptionOfAuditor><cmn:IdentificationNumberOfAuditor contextRef="duration_CY_IdentificationOfAuditorDimension_cmn_auditorIdentifier_only_1">mne47841</cmn:IdentificationNumberOfAuditor><mrv:ManagementsReview contextRef="duration_CY_only">Operating review&lt;br/&gt;Principal activity&lt;br/&gt;The objective of the Company is to carry out business activity in the fields of biotechnology, medicine and&lt;br/&gt;chemistry and related areas as defined by the board.&lt;br/&gt;Uncertainty regarding recognition and measurement&lt;br/&gt;The valuation of assets and liabilities is made in accordance with current accounting policies, and&lt;br/&gt;Management of the Company is of the opinion that no uncertainty is related to recognition and&lt;br/&gt;measurement.&lt;br/&gt;Unusual circumstances&lt;br/&gt;Other than ongoing COVID-19 pandemic, there have been no unusual circumstances affecting&lt;br/&gt;recognition and measurement in the financial year 2021.&lt;br/&gt;Profit/loss for the year (including comparison with forecasts previously announced)&lt;br/&gt;Our portfolio in Denmark is comprised of biologic brand Cimzia, our epilepsy drugs Briviact, Vimpat and&lt;br/&gt;Keppra. Next to epilepsy products we have Neupro helping people with Parkinson disease and part of&lt;br/&gt;established brands we commercialize Zyrtec, Xyzal as treatment for allergies and Xyrem used to treat&lt;br/&gt;adults who suffer from narcolepsy.&lt;br/&gt;The Company's revenue went down by -41.4% in 2021 compared to previous year. Cimzia revenue&lt;br/&gt;decreased by 65% versus last year, driven by not being in the tender of 2021.&lt;br/&gt;Parallel importer won the tender on the Prefilled Syringe, the Autoinjector sales was not impacted by this&lt;br/&gt;tender. Evenity had its first full year sales which triggered an upside of 0.8M€ versus last year sales.&lt;br/&gt;In the Neurology portfolio we see a slight decrease of the revenue evolution due to increased parallel&lt;br/&gt;import impacting Denmark.&lt;br/&gt;In Establish brands the revenues decreased by 48% mostly driven by Xyrem with high generic&lt;br/&gt;competition.&lt;br/&gt;The profit for 2021 amounts to DKK 3,016 thousand versus DKK 3,721 thousand in 2020 which is in line&lt;br/&gt;with previous year.&lt;br/&gt;The financial year was below the forecast due to increased parallel import but from a performance&lt;br/&gt;perspective the results for the year are considered satisfactory.&lt;br/&gt;Particular risks&lt;br/&gt;Risk management (operating and financial risk)&lt;br/&gt;A global Risk Management policy, applicable for the whole UCB Group and its affiliates worldwide,&lt;br/&gt;describes the UCB Group's commitment to provide an effective risk management system across the&lt;br/&gt;company in order to minimize its exposure to risks that could threaten the UCB Group's corporate&lt;br/&gt;objectives.&lt;br/&gt;The Board of Directors is responsible for approving the UCB Group's strategy, goals and objectives and&lt;br/&gt;overseeing the establishment, implementation and review of the Group's risk management system.&lt;br/&gt;The Board is assisted by the Audit Committee in its responsibility for the appreciation of risk&lt;br/&gt;management. The Audit Committee examines on a regular basis the areas where risks could significantly&lt;br/&gt;affect the financial situation or reputation of the UCB Group. The Audit Committee monitors the overall&lt;br/&gt;risk management process of UCB.&lt;br/&gt;The main risks faced by the Company relate to financial risks in particular pricing and foreign exchange&lt;br/&gt;risk.&lt;br/&gt;The Company's performance is impacted by parallel trade.&lt;br/&gt;Other insurable risks are insured by the Company to the extent that the directors consider appropriate&lt;br/&gt;having due regard to the considered impact from said risk.&lt;br/&gt;Environmental matters&lt;br/&gt;The Company's activities do not have any material environmental impact.&lt;br/&gt;Research and development activities&lt;br/&gt;The Company does not have any local research and development activities.&lt;br/&gt;Outlook&lt;br/&gt;Based on UCB’s current assessment of the Covid-19 pandemic, UCB remains confident in the&lt;br/&gt;fundamental underlying demand for its products in the short-term and its prospects for long-term growth.&lt;br/&gt;UCB will continue to closely follow evolving COVID-19 pandemic and its consequences to the business&lt;br/&gt;environment diligently to assess potential near- and mid-term challenges.&lt;br/&gt;Therefore, we expect no changes in the financing environment as well. We expect a result before tax for&lt;br/&gt;2022 of approximately the same amount as in 2021.</mrv:ManagementsReview><fsa:DisclosureOfAccountingPolicies contextRef="duration_CY_only">The annual report of UCB NORDIC A/S for 2021 has been prepared in accordance with the provisions&lt;br/&gt;applying to reporting class B entities with opt-in from higher accounting class under the Danish Financial&lt;br/&gt;Statements Act.&lt;br/&gt;The accounting policies used in the preparation of the financial statements are consistent with those of&lt;br/&gt;last year.&lt;br/&gt;Foreign currency translation&lt;br/&gt;On initial recognition, transactions denominated in foreign currencies are translated at the exchange rates&lt;br/&gt;at the transaction date. Foreign exchange differences arising between the exchange rates at the&lt;br/&gt;transaction date and the date of payment are recognised in the income statement as financial income or&lt;br/&gt;financial expenses.&lt;br/&gt;Receivables and payables and other monetary items denominated in foreign currencies are translated at&lt;br/&gt;the exchange rates at the balance sheet date. The difference between the exchange rates at the balance&lt;br/&gt;sheet date and the date at which the receivable or payable arose or was recognised in the latest financial&lt;br/&gt;statements is recognised in the income statement as financial income or financial expenses.</fsa:DisclosureOfAccountingPolicies><fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeStatementItems contextRef="duration_CY_only">Gross Profit&lt;br/&gt;With reference to section §81 of the Danish Financial Statements Act, revenue has not been disclosed in&lt;br/&gt;the annual report.&lt;br/&gt;Revenue&lt;br/&gt;Revenue from the sale of goods for resale and finished goods is recognised in the income statement&lt;br/&gt;when delivery and transfer of risk to the buyer has been made before year end.&lt;br/&gt;Revenue is recognised excluding VAT and net of discounts relating to sales.&lt;br/&gt;Cost of sales&lt;br/&gt;Cost of sales comprises costs incurred to generate revenue for the year. This item also comprises direct&lt;br/&gt;costs for goods for resale and changes to inventory of goods for resale.&lt;br/&gt;Other external costs&lt;br/&gt;Other external costs comprise distribution costs and costs related to sales, sales campaigns,&lt;br/&gt;administration, office premises, operating leases, etc.&lt;br/&gt;Staff costs&lt;br/&gt;Staff costs comprise wages and salaries, including holiday allowance, pension and other social security&lt;br/&gt;costs, etc., to the Company's employees, excluding reimbursements from public authorities.&lt;br/&gt;Financial income and expenses&lt;br/&gt;Financial income and expenses comprise interest, realised and unrealised exchange adjustments as well&lt;br/&gt;as extra payments and refunds under the on-account taxation scheme.&lt;br/&gt;Tax on profit for the year&lt;br/&gt;Tax for the year consists of current tax for the year and deferred tax for the year. The tax attributable to&lt;br/&gt;the profit for the year is recognised in the income statement, whereas the tax attributable to the equity&lt;br/&gt;transactions is recognised directly in equity.</fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeStatementItems><fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfAssetsAndLiabilities contextRef="duration_CY_only">Property, plant and equipment&lt;br/&gt;Leasehold improvements and equipment are measured at cost less accumulated depreciation and&lt;br/&gt;impairment losses.&lt;br/&gt;Cost comprises the purchase price and any costs directly attributable to the acquisition until the date on&lt;br/&gt;which the asset is available for use. Indirect production overheads and borrowing costs are not&lt;br/&gt;recognised in cost.&lt;br/&gt;Where individual components of an item of property, plant and equipment have different useful lives, they&lt;br/&gt;are accounted for as separate items, which are depreciated separately.&lt;br/&gt;The useful life and residual value are reassessed annually. Changes are treated as accounting estimates,&lt;br/&gt;and the effect on depreciation is recognised prospectively. The expected useful lives of the assets are as&lt;br/&gt;follows:&lt;br/&gt;Leasehold improvements and equipment 5 years&lt;br/&gt;Gains and losses on the disposal of property, plant and equipment are stated as the difference between&lt;br/&gt;the selling price less selling costs and the carrying amount at the date of disposal. Gains and losses are&lt;br/&gt;recognised in the income statement as other operating income or other operating costs, respectively.&lt;br/&gt;Impairment of property, plant and equipment&lt;br/&gt;The carrying amount of property, plant and equipment as well as investments in group enterprises is&lt;br/&gt;subject to an annual test for indications of impairment other than the decrease in value reflected by&lt;br/&gt;depreciation or amortisation.&lt;br/&gt;Impairment tests are conducted of individual assets or groups of assets when there is an indication that&lt;br/&gt;they may be impaired. Write-down is made to the recoverable amount if this is lower than the carrying&lt;br/&gt;amount.&lt;br/&gt;Inventories&lt;br/&gt;Inventories are measured at the lower of cost under the FIFO method and net realisable value.&lt;br/&gt;Receivables&lt;br/&gt;Receivables are measured at amortised cost.&lt;br/&gt;Write-down is made for bad debt losses where there is an objective indication that a receivable or a&lt;br/&gt;portfolio of receivables has been impaired. If there is an objective indication that an individual receivable&lt;br/&gt;has been impaired, write-down is made on an individual basis.&lt;br/&gt;Receivables with no objective indication of individual impairment are assessed for objective indication of&lt;br/&gt;impairment on a portfolio basis. The portfolios are primarily based on the debtors' registered offices and&lt;br/&gt;credit rating in accordance with the Company's credit risk management policy. The objective indicators&lt;br/&gt;used in relation to portfolios are determined on the basis of historical loss experience.&lt;br/&gt;Write-downs are calculated as the difference between the carrying amount of receivables and the present&lt;br/&gt;value of forecast cash flows, including the realisable value of any collateral received. The effective&lt;br/&gt;interest rate for the individual receivable or portfolio is used as discount rate.&lt;br/&gt;Other receivables consists of guarantee paid to third party.&lt;br/&gt;Prepayments&lt;br/&gt;Prepayments comprise prepaid expenses concerning subsequent financial years.&lt;br/&gt;Deferred tax assets and liabilities&lt;br/&gt;Deferred tax is recognised in respect of all temporary differences between the carrying amount and the&lt;br/&gt;tax base of assets and liabilities.&lt;br/&gt;Deferred tax is measured on the basis of the tax rules and tax rates that will be effective under the&lt;br/&gt;legislation at the balance sheet date when the deferred tax is expected to crystallise as current tax. In&lt;br/&gt;cases where the computation of the tax base may be made according to alternative tax rules, deferred tax&lt;br/&gt;is measured on the basis of the intended use of the asset and settlement of the liability, respectively.&lt;br/&gt;Deferred tax assets are measured at the value at which the asset is expected to be realised, either by&lt;br/&gt;elimination in tax on future earnings or by set off against deferred tax liabilities.&lt;br/&gt;Cash and cash equivalents&lt;br/&gt;Cash and cash equivalents comprise cash in banks.&lt;br/&gt;Equity&lt;br/&gt;Dividends&lt;br/&gt;Dividend distribution proposed by Management for the year is disclosed as a separate equity item.&lt;br/&gt;Provisions&lt;br/&gt;Provisions is booked when the company has a legal or de facto obligation due to an incident occurring&lt;br/&gt;before or at the balance sheet date, and it is probable that capital must be ceded in order to meet the&lt;br/&gt;obligation.&lt;br/&gt;Liabilities&lt;br/&gt;Payables to credit institutions are recognized at cost at the date of borrowing, equivalent to proceeds&lt;br/&gt;received less transaction cost paid.&lt;br/&gt;Trade payables and payables to group entities are recognized at cost.&lt;br/&gt;Subsequently these financial liabilities are measured at cost.&lt;br/&gt;Other liabilities are measured at net realization value.</fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfAssetsAndLiabilities><fsa:ExplanationOfNotDisclosingCashFlowsStatements contextRef="duration_CY_only">Pursuant to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been&lt;br/&gt;prepared. The Company's cash flows are included in the cash flow statement in the consolidated financial&lt;br/&gt;statements of UCB S.A.</fsa:ExplanationOfNotDisclosingCashFlowsStatements><fsa:GrossProfitLoss contextRef="duration_CY_only" decimals="-3" unitRef="DKK">60527000</fsa:GrossProfitLoss><fsa:GrossProfitLoss contextRef="duration_LY_RetrospectiveInformationDimension_cmn_PreviousYearMember_only" decimals="-3" unitRef="DKK">46217000</fsa:GrossProfitLoss><fsa:GrossProfitLoss contextRef="duration_2Y_RetrospectiveInformationDimension_cmn_TwoYearsAgoMember_only" decimals="-3" unitRef="DKK">39541000</fsa:GrossProfitLoss><fsa:GrossProfitLoss contextRef="duration_3Y_RetrospectiveInformationDimension_cmn_ThreeYearsAgoMember_only" decimals="-3" unitRef="DKK">34615000</fsa:GrossProfitLoss><fsa:GrossProfitLoss contextRef="duration_4Y_RetrospectiveInformationDimension_cmn_FourYearsAgoMember_only" decimals="-3" unitRef="DKK">34824000</fsa:GrossProfitLoss><fsa:GrossProfitLoss contextRef="duration_LY_only" decimals="-3" unitRef="DKK">46217000</fsa:GrossProfitLoss><fsa:ResultsFromNetFinancials contextRef="duration_CY_only" decimals="-3" unitRef="DKK">3817000</fsa:ResultsFromNetFinancials><fsa:ResultsFromNetFinancials contextRef="duration_LY_RetrospectiveInformationDimension_cmn_PreviousYearMember_only" decimals="-3" unitRef="DKK">4650000</fsa:ResultsFromNetFinancials><fsa:ResultsFromNetFinancials contextRef="duration_2Y_RetrospectiveInformationDimension_cmn_TwoYearsAgoMember_only" decimals="-3" unitRef="DKK">4246000</fsa:ResultsFromNetFinancials><fsa:ResultsFromNetFinancials contextRef="duration_3Y_RetrospectiveInformationDimension_cmn_ThreeYearsAgoMember_only" decimals="-3" unitRef="DKK">4403000</fsa:ResultsFromNetFinancials><fsa:ResultsFromNetFinancials contextRef="duration_4Y_RetrospectiveInformationDimension_cmn_FourYearsAgoMember_only" decimals="-3" unitRef="DKK">4997000</fsa:ResultsFromNetFinancials><fsa:ProfitLossFromOrdinaryOperatingActivities contextRef="duration_CY_only" decimals="-3" unitRef="DKK">4032000</fsa:ProfitLossFromOrdinaryOperatingActivities><fsa:ProfitLossFromOrdinaryOperatingActivities contextRef="duration_LY_RetrospectiveInformationDimension_cmn_PreviousYearMember_only" decimals="-3" unitRef="DKK">4948000</fsa:ProfitLossFromOrdinaryOperatingActivities><fsa:ProfitLossFromOrdinaryOperatingActivities contextRef="duration_2Y_RetrospectiveInformationDimension_cmn_TwoYearsAgoMember_only" decimals="-3" unitRef="DKK">4514000</fsa:ProfitLossFromOrdinaryOperatingActivities><fsa:ProfitLossFromOrdinaryOperatingActivities contextRef="duration_3Y_RetrospectiveInformationDimension_cmn_ThreeYearsAgoMember_only" decimals="-3" unitRef="DKK">4560000</fsa:ProfitLossFromOrdinaryOperatingActivities><fsa:ProfitLossFromOrdinaryOperatingActivities contextRef="duration_4Y_RetrospectiveInformationDimension_cmn_FourYearsAgoMember_only" decimals="-3" unitRef="DKK">5319000</fsa:ProfitLossFromOrdinaryOperatingActivities><fsa:ProfitLossFromOrdinaryOperatingActivities contextRef="duration_LY_only" decimals="-3" unitRef="DKK">4948000</fsa:ProfitLossFromOrdinaryOperatingActivities><fsa:ProfitLoss contextRef="duration_CY_only" decimals="-3" unitRef="DKK">3016000</fsa:ProfitLoss><fsa:ProfitLoss contextRef="duration_LY_RetrospectiveInformationDimension_cmn_PreviousYearMember_only" decimals="-3" unitRef="DKK">3721000</fsa:ProfitLoss><fsa:ProfitLoss contextRef="duration_2Y_RetrospectiveInformationDimension_cmn_TwoYearsAgoMember_only" decimals="-3" unitRef="DKK">3591000</fsa:ProfitLoss><fsa:ProfitLoss contextRef="duration_3Y_RetrospectiveInformationDimension_cmn_ThreeYearsAgoMember_only" decimals="-3" unitRef="DKK">3268000</fsa:ProfitLoss><fsa:ProfitLoss contextRef="duration_4Y_RetrospectiveInformationDimension_cmn_FourYearsAgoMember_only" decimals="-3" unitRef="DKK">3739000</fsa:ProfitLoss><fsa:ProfitLoss contextRef="duration_LY_only" decimals="-3" unitRef="DKK">3721000</fsa:ProfitLoss><fsa:ProfitLoss contextRef="duration_CY_ResultDistributionDimension_fsa_ProposedDividendRecognisedInEquityMember_only" decimals="-3" unitRef="DKK">3000000</fsa:ProfitLoss><fsa:ProfitLoss contextRef="duration_LY_ResultDistributionDimension_fsa_ProposedDividendRecognisedInEquityMember_only" decimals="-3" unitRef="DKK">0</fsa:ProfitLoss><fsa:ProfitLoss contextRef="duration_CY_ResultDistributionDimension_fsa_RetainedEarningsMember_only" decimals="-3" unitRef="DKK">16000</fsa:ProfitLoss><fsa:ProfitLoss contextRef="duration_LY_ResultDistributionDimension_fsa_RetainedEarningsMember_only" decimals="-3" unitRef="DKK">3721000</fsa:ProfitLoss><fsa:ProfitLoss contextRef="duration_CY_ClassesOfEquityDimension_fsa_ContributedCapitalMember_only" decimals="-3" unitRef="DKK">0</fsa:ProfitLoss><fsa:ProfitLoss contextRef="duration_CY_ClassesOfEquityDimension_fsa_RetainedEarningsMember_only" decimals="-3" unitRef="DKK">3016000</fsa:ProfitLoss><fsa:ProfitLoss contextRef="duration_CY_ClassesOfEquityDimension_fsa_ProposedDividendRecognisedInEquityMember_only" decimals="-3" unitRef="DKK">0</fsa:ProfitLoss><fsa:Assets contextRef="instant_CY_only" decimals="-3" unitRef="DKK">59202000</fsa:Assets><fsa:Assets contextRef="instant_LY_RetrospectiveInformationDimension_cmn_PreviousYearMember_only" decimals="-3" unitRef="DKK">60523000</fsa:Assets><fsa:Assets contextRef="instant_2Y_RetrospectiveInformationDimension_cmn_TwoYearsAgoMember_only" decimals="-3" unitRef="DKK">58816000</fsa:Assets><fsa:Assets contextRef="instant_3Y_RetrospectiveInformationDimension_cmn_ThreeYearsAgoMember_only" decimals="-3" unitRef="DKK">68871000</fsa:Assets><fsa:Assets contextRef="instant_4Y_RetrospectiveInformationDimension_cmn_FourYearsAgoMember_only" decimals="-3" unitRef="DKK">80784000</fsa:Assets><fsa:Assets contextRef="instant_LY_only" decimals="-3" unitRef="DKK">60523000</fsa:Assets><fsa:InvestmentInPropertyPlantAndEquipment contextRef="duration_CY_only" decimals="-3" unitRef="DKK">0</fsa:InvestmentInPropertyPlantAndEquipment><fsa:InvestmentInPropertyPlantAndEquipment contextRef="duration_LY_RetrospectiveInformationDimension_cmn_PreviousYearMember_only" decimals="-3" unitRef="DKK">0</fsa:InvestmentInPropertyPlantAndEquipment><fsa:InvestmentInPropertyPlantAndEquipment contextRef="duration_2Y_RetrospectiveInformationDimension_cmn_TwoYearsAgoMember_only" decimals="-3" unitRef="DKK">0</fsa:InvestmentInPropertyPlantAndEquipment><fsa:InvestmentInPropertyPlantAndEquipment contextRef="duration_3Y_RetrospectiveInformationDimension_cmn_ThreeYearsAgoMember_only" decimals="-3" unitRef="DKK">0</fsa:InvestmentInPropertyPlantAndEquipment><fsa:InvestmentInPropertyPlantAndEquipment contextRef="duration_4Y_RetrospectiveInformationDimension_cmn_FourYearsAgoMember_only" decimals="-3" unitRef="DKK">320000</fsa:InvestmentInPropertyPlantAndEquipment><mrv:SolvencyRatio contextRef="duration_CY_only" decimals="3" unitRef="pure">0.240</mrv:SolvencyRatio><mrv:SolvencyRatio contextRef="duration_LY_RetrospectiveInformationDimension_cmn_PreviousYearMember_only" decimals="3" unitRef="pure">0.180</mrv:SolvencyRatio><mrv:SolvencyRatio contextRef="duration_2Y_RetrospectiveInformationDimension_cmn_TwoYearsAgoMember_only" decimals="3" unitRef="pure">0.180</mrv:SolvencyRatio><mrv:SolvencyRatio contextRef="duration_3Y_RetrospectiveInformationDimension_cmn_ThreeYearsAgoMember_only" decimals="3" unitRef="pure">0.150</mrv:SolvencyRatio><mrv:SolvencyRatio contextRef="duration_4Y_RetrospectiveInformationDimension_cmn_FourYearsAgoMember_only" decimals="3" unitRef="pure">0.130</mrv:SolvencyRatio><mrv:ReturnOnEquity contextRef="duration_CY_only" decimals="3" unitRef="pure">0.240</mrv:ReturnOnEquity><mrv:ReturnOnEquity contextRef="duration_LY_RetrospectiveInformationDimension_cmn_PreviousYearMember_only" decimals="3" unitRef="pure">0.340</mrv:ReturnOnEquity><mrv:ReturnOnEquity contextRef="duration_2Y_RetrospectiveInformationDimension_cmn_TwoYearsAgoMember_only" decimals="3" unitRef="pure">0.340</mrv:ReturnOnEquity><mrv:ReturnOnEquity contextRef="duration_3Y_RetrospectiveInformationDimension_cmn_ThreeYearsAgoMember_only" decimals="3" unitRef="pure">0.320</mrv:ReturnOnEquity><mrv:ReturnOnEquity contextRef="duration_4Y_RetrospectiveInformationDimension_cmn_FourYearsAgoMember_only" decimals="3" unitRef="pure">0.360</mrv:ReturnOnEquity><mrv:InformationOnCalculationOfKeyFiguresAndFinancialRatios contextRef="duration_CY_only">The financial ratios have been calculated as follows:&lt;br/&gt;&lt;br/&gt;Return on equity &lt;br/&gt;Profit/loss for the year x 100/&lt;br/&gt;Average equity&lt;br/&gt;&lt;br/&gt;Solvency ratio &lt;br/&gt;Equity at year end x 100/&lt;br/&gt;Total assets at year end</mrv:InformationOnCalculationOfKeyFiguresAndFinancialRatios><fsa:EmployeeBenefitsExpense contextRef="duration_CY_only" decimals="-3" unitRef="DKK">56434000</fsa:EmployeeBenefitsExpense><fsa:EmployeeBenefitsExpense contextRef="duration_LY_only" decimals="-3" unitRef="DKK">41208000</fsa:EmployeeBenefitsExpense><fsa:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="duration_CY_only" decimals="-3" unitRef="DKK">61000</fsa:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss><fsa:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="duration_LY_only" decimals="-3" unitRef="DKK">61000</fsa:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss><fsa:OtherFinanceIncome contextRef="duration_CY_only" decimals="-3" unitRef="DKK">69000</fsa:OtherFinanceIncome><fsa:OtherFinanceIncome contextRef="duration_LY_only" decimals="-3" unitRef="DKK">110000</fsa:OtherFinanceIncome><fsa:OtherFinanceExpenses contextRef="duration_CY_only" decimals="-3" unitRef="DKK">284000</fsa:OtherFinanceExpenses><fsa:OtherFinanceExpenses contextRef="duration_LY_only" decimals="-3" unitRef="DKK">408000</fsa:OtherFinanceExpenses><fsa:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="duration_CY_only" decimals="-3" unitRef="DKK">3817000</fsa:ProfitLossFromOrdinaryActivitiesBeforeTax><fsa:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="duration_LY_only" decimals="-3" unitRef="DKK">4650000</fsa:ProfitLossFromOrdinaryActivitiesBeforeTax><fsa:TaxExpense contextRef="duration_CY_only" decimals="-3" unitRef="DKK">802000</fsa:TaxExpense><fsa:TaxExpense contextRef="duration_LY_only" decimals="-3" unitRef="DKK">929000</fsa:TaxExpense><fsa:LeaseholdImprovements contextRef="instant_CY_only" decimals="-3" unitRef="DKK">49000</fsa:LeaseholdImprovements><fsa:LeaseholdImprovements contextRef="instant_LY_only" decimals="-3" unitRef="DKK">137000</fsa:LeaseholdImprovements><fsa:OtherLongtermReceivables contextRef="instant_CY_only" decimals="-3" unitRef="DKK">463000</fsa:OtherLongtermReceivables><fsa:OtherLongtermReceivables contextRef="instant_LY_only" decimals="-3" unitRef="DKK">341000</fsa:OtherLongtermReceivables><fsa:NoncurrentAssets contextRef="instant_CY_only" decimals="-3" unitRef="DKK">512000</fsa:NoncurrentAssets><fsa:NoncurrentAssets contextRef="instant_LY_only" decimals="-3" unitRef="DKK">478000</fsa:NoncurrentAssets><fsa:ManufacturedGoodsAndGoodsForResale contextRef="instant_CY_only" decimals="-3" unitRef="DKK">16343000</fsa:ManufacturedGoodsAndGoodsForResale><fsa:ManufacturedGoodsAndGoodsForResale contextRef="instant_LY_only" decimals="-3" unitRef="DKK">14851000</fsa:ManufacturedGoodsAndGoodsForResale><fsa:ShorttermTradeReceivables contextRef="instant_CY_only" decimals="-3" unitRef="DKK">10887000</fsa:ShorttermTradeReceivables><fsa:ShorttermTradeReceivables contextRef="instant_LY_only" decimals="-3" unitRef="DKK">17343000</fsa:ShorttermTradeReceivables><fsa:ShorttermReceivablesFromGroupEnterprises contextRef="instant_CY_only" decimals="-3" unitRef="DKK">19693000</fsa:ShorttermReceivablesFromGroupEnterprises><fsa:ShorttermReceivablesFromGroupEnterprises contextRef="instant_LY_only" decimals="-3" unitRef="DKK">13788000</fsa:ShorttermReceivablesFromGroupEnterprises><fsa:CurrentDeferredTaxAssets contextRef="instant_CY_only" decimals="-3" unitRef="DKK">1286000</fsa:CurrentDeferredTaxAssets><fsa:CurrentDeferredTaxAssets contextRef="instant_LY_only" decimals="-3" unitRef="DKK">178000</fsa:CurrentDeferredTaxAssets><fsa:OtherShorttermReceivables contextRef="instant_CY_only" decimals="-3" unitRef="DKK">0</fsa:OtherShorttermReceivables><fsa:OtherShorttermReceivables contextRef="instant_LY_only" decimals="-3" unitRef="DKK">0</fsa:OtherShorttermReceivables><fsa:DeferredIncomeAssets contextRef="instant_CY_only" decimals="-3" unitRef="DKK">169000</fsa:DeferredIncomeAssets><fsa:DeferredIncomeAssets contextRef="instant_LY_only" decimals="-3" unitRef="DKK">192000</fsa:DeferredIncomeAssets><fsa:ShorttermReceivables contextRef="instant_CY_only" decimals="-3" unitRef="DKK">32035000</fsa:ShorttermReceivables><fsa:ShorttermReceivables contextRef="instant_LY_only" decimals="-3" unitRef="DKK">31501000</fsa:ShorttermReceivables><fsa:CashAndCashEquivalents contextRef="instant_CY_only" decimals="-3" unitRef="DKK">10312000</fsa:CashAndCashEquivalents><fsa:CashAndCashEquivalents contextRef="instant_LY_only" decimals="-3" unitRef="DKK">13693000</fsa:CashAndCashEquivalents><fsa:CurrentAssets contextRef="instant_CY_only" decimals="-3" unitRef="DKK">58690000</fsa:CurrentAssets><fsa:CurrentAssets contextRef="instant_LY_only" decimals="-3" unitRef="DKK">60045000</fsa:CurrentAssets><fsa:ContributedCapital contextRef="instant_CY_only" decimals="-3" unitRef="DKK">850000</fsa:ContributedCapital><fsa:ContributedCapital contextRef="instant_LY_only" decimals="-3" unitRef="DKK">850000</fsa:ContributedCapital><fsa:RetainedEarnings contextRef="instant_CY_only" decimals="-3" unitRef="DKK">10264000</fsa:RetainedEarnings><fsa:RetainedEarnings contextRef="instant_LY_only" decimals="-3" unitRef="DKK">10244000</fsa:RetainedEarnings><fsa:ProposedDividendRecognisedInEquity contextRef="instant_CY_only" decimals="-3" unitRef="DKK">3000000</fsa:ProposedDividendRecognisedInEquity><fsa:ProposedDividendRecognisedInEquity contextRef="instant_LY_only" decimals="-3" unitRef="DKK">0</fsa:ProposedDividendRecognisedInEquity><fsa:Equity contextRef="instant_CY_only" decimals="-3" unitRef="DKK">14114000</fsa:Equity><fsa:Equity contextRef="instant_LY_only" decimals="-3" unitRef="DKK">11094000</fsa:Equity><fsa:Equity contextRef="instant_CY_ClassesOfEquityDimension_fsa_ContributedCapitalMember_only_start" decimals="-3" unitRef="DKK">850000</fsa:Equity><fsa:Equity contextRef="instant_CY_ClassesOfEquityDimension_fsa_ContributedCapitalMember_only" decimals="-3" unitRef="DKK">850000</fsa:Equity><fsa:Equity contextRef="instant_CY_ClassesOfEquityDimension_fsa_RetainedEarningsMember_only_start" decimals="-3" unitRef="DKK">10244000</fsa:Equity><fsa:Equity contextRef="instant_CY_ClassesOfEquityDimension_fsa_RetainedEarningsMember_only" decimals="-3" unitRef="DKK">10264000</fsa:Equity><fsa:Equity contextRef="instant_CY_ClassesOfEquityDimension_fsa_ProposedDividendRecognisedInEquityMember_only_start" decimals="-3" unitRef="DKK">0</fsa:Equity><fsa:Equity contextRef="instant_CY_ClassesOfEquityDimension_fsa_ProposedDividendRecognisedInEquityMember_only" decimals="-3" unitRef="DKK">3000000</fsa:Equity><fsa:Equity contextRef="instant_CY_only_start" decimals="-3" unitRef="DKK">11094000</fsa:Equity><fsa:OtherProvisions contextRef="instant_CY_only" decimals="-3" unitRef="DKK">5461000</fsa:OtherProvisions><fsa:OtherProvisions contextRef="instant_LY_only" decimals="-3" unitRef="DKK">3323000</fsa:OtherProvisions><fsa:Provisions contextRef="instant_CY_only" decimals="-3" unitRef="DKK">5461000</fsa:Provisions><fsa:Provisions contextRef="instant_LY_only" decimals="-3" unitRef="DKK">3323000</fsa:Provisions><fsa:ShorttermTradePayables contextRef="instant_CY_only" decimals="-3" unitRef="DKK">4357000</fsa:ShorttermTradePayables><fsa:ShorttermTradePayables contextRef="instant_LY_only" decimals="-3" unitRef="DKK">8410000</fsa:ShorttermTradePayables><fsa:ShorttermPayablesToGroupEnterprises contextRef="instant_CY_only" decimals="-3" unitRef="DKK">24677000</fsa:ShorttermPayablesToGroupEnterprises><fsa:ShorttermPayablesToGroupEnterprises contextRef="instant_LY_only" decimals="-3" unitRef="DKK">26534000</fsa:ShorttermPayablesToGroupEnterprises><fsa:ShorttermTaxPayables contextRef="instant_CY_only" decimals="-3" unitRef="DKK">1350000</fsa:ShorttermTaxPayables><fsa:ShorttermTaxPayables contextRef="instant_LY_only" decimals="-3" unitRef="DKK">123000</fsa:ShorttermTaxPayables><fsa:OtherShorttermPayables contextRef="instant_CY_only" decimals="-3" unitRef="DKK">9243000</fsa:OtherShorttermPayables><fsa:OtherShorttermPayables contextRef="instant_LY_only" decimals="-3" unitRef="DKK">11039000</fsa:OtherShorttermPayables><fsa:ShorttermLiabilitiesOtherThanProvisions contextRef="instant_CY_only" decimals="-3" unitRef="DKK">39627000</fsa:ShorttermLiabilitiesOtherThanProvisions><fsa:ShorttermLiabilitiesOtherThanProvisions contextRef="instant_LY_only" decimals="-3" unitRef="DKK">46106000</fsa:ShorttermLiabilitiesOtherThanProvisions><fsa:LiabilitiesOtherThanProvisions contextRef="instant_CY_only" decimals="-3" unitRef="DKK">39627000</fsa:LiabilitiesOtherThanProvisions><fsa:LiabilitiesOtherThanProvisions contextRef="instant_LY_only" decimals="-3" unitRef="DKK">46106000</fsa:LiabilitiesOtherThanProvisions><fsa:LiabilitiesAndEquity contextRef="instant_CY_only" decimals="-3" unitRef="DKK">59202000</fsa:LiabilitiesAndEquity><fsa:LiabilitiesAndEquity contextRef="instant_LY_only" decimals="-3" unitRef="DKK">60523000</fsa:LiabilitiesAndEquity><fsa:IncreaseDecreaseOfEquityThroughCorrectionsOfErrors contextRef="duration_CY_ClassesOfEquityDimension_fsa_ContributedCapitalMember_only" decimals="-3" unitRef="DKK">0</fsa:IncreaseDecreaseOfEquityThroughCorrectionsOfErrors><fsa:IncreaseDecreaseOfEquityThroughCorrectionsOfErrors contextRef="duration_CY_ClassesOfEquityDimension_fsa_RetainedEarningsMember_only" decimals="-3" unitRef="DKK">4000</fsa:IncreaseDecreaseOfEquityThroughCorrectionsOfErrors><fsa:IncreaseDecreaseOfEquityThroughCorrectionsOfErrors contextRef="duration_CY_ClassesOfEquityDimension_fsa_ProposedDividendRecognisedInEquityMember_only" decimals="-3" unitRef="DKK">0</fsa:IncreaseDecreaseOfEquityThroughCorrectionsOfErrors><fsa:IncreaseDecreaseOfEquityThroughCorrectionsOfErrors contextRef="duration_CY_only" decimals="-3" unitRef="DKK">4000</fsa:IncreaseDecreaseOfEquityThroughCorrectionsOfErrors><fsa:Dividend contextRef="duration_CY_ClassesOfEquityDimension_fsa_ContributedCapitalMember_only" decimals="-3" unitRef="DKK">0</fsa:Dividend><fsa:Dividend contextRef="duration_CY_ClassesOfEquityDimension_fsa_RetainedEarningsMember_only" decimals="-3" unitRef="DKK">3000000</fsa:Dividend><fsa:Dividend contextRef="duration_CY_ClassesOfEquityDimension_fsa_ProposedDividendRecognisedInEquityMember_only" decimals="-3" unitRef="DKK">-3000000</fsa:Dividend><fsa:Dividend contextRef="duration_CY_only" decimals="-3" unitRef="DKK">0</fsa:Dividend><fsa:DisclosureOfEmployeeBenefitsExpense contextRef="duration_CY_only">Wages and Salaries 52,058 37,942&lt;br/&gt;Pensions 4,048 2,977&lt;br/&gt;Other social security costs 328 289&lt;br/&gt;56,434 41,208</fsa:DisclosureOfEmployeeBenefitsExpense><fsa:InformationOnRemunerationOfManagementCategoriesAndSpecialIncentiveProgrammes contextRef="duration_CY_only">According to section 98 B(3) of the Danish Financial Statements Act, remuneration to the Executive&lt;br/&gt;Board has not been disclosed.</fsa:InformationOnRemunerationOfManagementCategoriesAndSpecialIncentiveProgrammes><fsa:AverageNumberOfEmployees contextRef="duration_CY_only" decimals="0" unitRef="pure">40</fsa:AverageNumberOfEmployees><fsa:AverageNumberOfEmployees contextRef="duration_LY_only" decimals="0" unitRef="pure">31</fsa:AverageNumberOfEmployees><fsa:DisclosureOfOtherFinanceIncome contextRef="duration_CY_only">Interest received from group entities 15 57&lt;br/&gt;Other financial income — 6&lt;br/&gt;Exchange gains 54 47&lt;br/&gt;69 110</fsa:DisclosureOfOtherFinanceIncome><fsa:DisclosureOfOtherFinanceExpenses contextRef="duration_CY_only">Interest paid to group entities 218 232&lt;br/&gt;Other financial expenses 50 65&lt;br/&gt;Exchange losses 16 111&lt;br/&gt;284 408</fsa:DisclosureOfOtherFinanceExpenses><fsa:DisclosureOfTaxExpenses contextRef="duration_CY_only">Current tax for the year 1,910 607&lt;br/&gt;Deferred tax for the year (1,108) 135&lt;br/&gt;Adjustment of tax concerning previous years — 187&lt;br/&gt;802 929</fsa:DisclosureOfTaxExpenses><fsa:DisclosureOfPropertyPlantAndEquipment contextRef="duration_CY_only">Leasehold&lt;br/&gt;improvements &amp;&lt;br/&gt;equipment&lt;br/&gt;Cost at 1 January 2021 330&lt;br/&gt;Cost at 31 December 2021 302&lt;br/&gt;Depreciation and impairment losses at 1 January 2021 (192)&lt;br/&gt;Depreciation for the year (61)&lt;br/&gt;Depreciation and impairment losses at 31 December 2021 (253)&lt;br/&gt;Carrying amount at 31 December 2021 49</fsa:DisclosureOfPropertyPlantAndEquipment><fsa:InformationOnOtherReceivables contextRef="duration_CY_only">Other&lt;br/&gt;receivables&lt;br/&gt;Cost at 1 January 2021 341&lt;br/&gt;Additions 122&lt;br/&gt;Disposals —&lt;br/&gt;Cost at 31 December 2021 463&lt;br/&gt;Carrying amount at 31 December 2021 463</fsa:InformationOnOtherReceivables><fsa:ExplanationOfPrepayments contextRef="duration_CY_only">Prepayments comprise prepaid expenses concerning subsequent financial years.&lt;br/&gt;DKK'000 2021 2020&lt;br/&gt;169 192</fsa:ExplanationOfPrepayments><fsa:DisclosureOfEquity contextRef="duration_CY_only">The contributed capital consists of 850,000 shares of a nominal value of DKK 1 each.&lt;br/&gt;No shares carry any special rights.</fsa:DisclosureOfEquity><fsa:DisclosureOfProvisionsForDeferredTax contextRef="duration_CY_only">Deferred tax at 1 January 2021 178 313&lt;br/&gt;Deferred tax adjustment for the year in the income statement 1,108 (135)&lt;br/&gt;1,286 178&lt;br/&gt;Provisions for deferred tax relate to:&lt;br/&gt;Property, plant and equipment 11 (1)&lt;br/&gt;Stock Options 1,275 179&lt;br/&gt;1,286 178</fsa:DisclosureOfProvisionsForDeferredTax><fsa:DisclosureOfRelatedParties contextRef="duration_CY_only">Related party transactions&lt;br/&gt;In accordance with section 98 c(7) of the Danish Financial Statements Act, the Company has not&lt;br/&gt;disclosed any related party transactions as they were conducted on an arm's length basis.&lt;br/&gt;Controlling interest&lt;br/&gt;UCB Pharma SA, Allée de la Recherche 60, 1070 Brussels, Belgium.&lt;br/&gt;Consolidated financial statements&lt;br/&gt;The Company is included in the Group Annual Report of UCB S.A.&lt;br/&gt;The Group Annual Report of UCB S.A may be obtained at the following address:&lt;br/&gt;Allée de la Recherche 60,&lt;br/&gt;1070 Brussels,&lt;br/&gt;Belgium</fsa:DisclosureOfRelatedParties><fsa:OtherDisclosures contextRef="duration_CY_only">Provisions for the share option plan&lt;br/&gt;Based on the performance of the employee during the reference year and on his/her job level, UCB&lt;br/&gt;grants stock awards and stock options on April 1st in the year following the performance year.&lt;br/&gt;Stock awards are a promise to deliver a number of shares on the third anniversary of grant on condition&lt;br/&gt;that the person remains employed up to and including on the vesting date. The stock awards are granted&lt;br/&gt;by UCB S.A. The stock awards are share based : UCB SA buys the shares on the market, delivers them&lt;br/&gt;to the employee and recharges the cost to the affiliate.&lt;br/&gt;A Stock Option gives you the right to buy a UCB share at a certain price (exercise price) during the&lt;br/&gt;exercise period. Upon exercise of the stock options, UCB SA delivers the shares to the employee. In the&lt;br/&gt;year of grant, UCB SA recharges the cost of the grant to the affiliate.</fsa:OtherDisclosures><fsa:DisclosureOfContingentLiabilities contextRef="duration_CY_only">The Company has leases regarding company cars, printers and furniture, and has committed to give at&lt;br/&gt;least six months' notice on the office rental.&lt;br/&gt;At 31 December 2021, the Company has total contingent liabilities within one year of DKK 2,126&lt;br/&gt;thousand and after one year of 1,381 DKK thousand. In the prior year, the Company had total contingent&lt;br/&gt;liabilities within one year of DKK 2,100 thousand and after one year of DKK 2,648 thousand.</fsa:DisclosureOfContingentLiabilities></xbrli:xbrl>